Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Cash flows from operating activities:
Net income (loss)	$ 42,812	$ 52,057	$ 65,812
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Net unrealized (gain) loss related to derivative instruments	2,014	(1,734)	(974)
Depreciation and amortization	100,882	98,397	66,409
Loss (gain) on disposal or impairment, net	11,472	32,592	(216)
Equity earnings from investments	(81,386)	(64,199)	(52,477)
Gain on issuance of common units by equity method investee	(6,385)	(29,020)	(26,873)
Gain on sale of common units of equity method investee	(14,517)	(34,211)	0
Distributions from equity investments	95,429	85,261	63,651
Amortization and write down of debt issuance costs	5,102	3,632	2,732
Deferred tax expense (benefit)	29,197	36,148	(36,274)
Non-cash compensation expense	10,617	8,386	7,330
Excess tax benefit from equity-based awards	0	(1,650)	0
(Gain) loss on fair value of warrants	0	13,423	46,433
Provision for uncollectible accounts receivable, net of recoveries	208	360	(372)
Inventory valuation adjustment	2,590	5,667	0
Currency (gain) loss	(1,067)	(86)	(1,633)
Changes in operating assets and liabilities (Note 22)	(15,206)	(23,365)	39,861
Net cash provided by operating activities	181,762	181,658	173,409
Cash flows from investing activities:
Capital expenditures	(479,530)	(270,506)	(215,609)
Proceeds from sale of long-lived assets	3,688	4,445	1,279
Investments in non-consolidated subsidiaries	(46,730)	(71,131)	(173,868)
Payments to acquire businesses	0	(44,508)	(362,456)
Proceeds from sale of common units of equity method investee	56,318	79,741	0
Distributions from equity method investments in excess of equity in earnings	24,113	11,734	12,246
Net cash provided by (used in) investing activities	(442,141)	(290,225)	(738,408)
Cash flows from financing activities:
Debt issuance costs	(6,289)	(8,686)	(14,936)
Borrowings on debt and other obligations	867,208	1,254,244	1,268,474
Principal payments on debt and other obligations	(560,049)	(1,102,272)	(859,412)
Distributions to noncontrolling interests	(40,410)	(28,494)	(17,647)
Proceeds from warrant exercises	0	1,451	225
Repurchase of common stock	(4,261)	(719)	(371)
Dividends paid	(69,514)	(44,206)	(25,429)
Proceeds from issuance of common stock under employee stock purchase plan	1,223	340	0
Excess tax benefit from equity-based awards	0	1,650	0
Proceeds from issuance of Rose Rock Midstream, L.P. common units, net of offering costs	89,119	0	210,226
Net cash provided by (used in) financing activities	277,027	73,308	561,130
Effect of exchange rate changes on cash and cash equivalents	850	(3,494)	3,191
Change in cash and cash equivalents	17,498	(38,753)	(678)
Cash and cash equivalents at beginning of period	40,598	79,351	80,029
Cash and cash equivalents at end of period	$ 58,096	$ 40,598	$ 79,351